Focusing HIV prevention on those most likely to transmit the virus

AIDS Education and Prevention

Volumn 19, Issue 4, 2007, Pages 275-288

  West, Gary R ^a   Corneli, Amy L ^a   Best, Kim ^a   Kurkjian, Katie M ^a   Cates Jr , William ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE MANAGEMENT; CIRCUMCISION; COST MINIMIZATION ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; ENZYME IMMUNOASSAY; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HERPES SIMPLEX; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; SOCIAL NETWORK; VIRUS LOAD; VIRUS TRANSMISSION;

AIDS SERODIAGNOSIS; CASE MANAGEMENT; COMORBIDITY; CONTACT TRACING; DIRECTIVE COUNSELING; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; NEEDLE SHARING; PEER GROUP; POLYMERASE CHAIN REACTION; PRIMARY PREVENTION; RISK FACTORS; RISK-TAKING; SEXUAL PARTNERS; SOCIAL BEHAVIOR; SOCIAL SUPPORT; UNSAFE SEX; VIRAL LOAD;

EID: 34548051991     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2007.19.4.275     Document Type: Article

References (77)

1. Amirkhanian, Y. A., Kelly, J. A., Kabakchieva, E., Kirsanova, A. V., Vassileva, S., Takacs, J., et al. (2005). A randomized social network HIV prevention trial with young men who have sex with men in Russia and Bulgaria. AIDS, 19(16), 1897-1905.
2. Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J. , Sitta, R., & Puren, A. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. Public Library of Science Medicine, 2(11), e298.
3. Balakrishnan, P., Solomon, S., Kumarasamy, N., & Mayer, K. H. (2005). Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries. Journal of Medical Research, 121(4), 345-55.
4. Brenner, B. G., Roger, M., Routy, J. P., Moisi, D., Ntemgwa, M., Matte, C., et al. (2007). High rates of forward transmission events after acute/early HIV-1 infection. Journal of Infectious Diseases, 195(7), 951-959.
5. Cates, W. Jr. (2006).Technological advances in HIV prevention. In J.P. Phair, A. Poppa, E. King (Eds.), HIV/AIDS annual update 2006 (pp. 205-220). New York: Clinical Care Options HIV.
6. Cates, W., Jr, Chesney, M. A., & Cohen, M. S. (1997). Primary HIV infection - A public health opportunity. American Journal of Public Health, 87(12), 1928-30.
7. Centers for Disease Control and Prevention. (1992). Epidemic early syphilis-Montgomery County, Alabama, 1990-1991. Morbidity and Mortality Weekly Report, 41(42), 790-4.
8. Centers for Disease Control and Prevention. (1997). HIV prevention case management guidance. Atlanta, GA: Author.
9. Centers for Disease Control and Prevention. (1998). HIV partner counseling and referral services. Atlanta, GA: Centers for Disease Control and Prevention.
10. Centers for Disease Control and Prevention. (2001). Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morbidity and MortalityWeekly Report, 50, 1-42.
11. Centers for Disease Control and Prevention. (2005a). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Morbidity and Mortality Weekly Report, 54, 1-20.
12. Centers for Disease Control and Prevention. (2005b). CDC trials of daily oral tenofovir for preventing HIV infection (CDC fact sheet). Atlanta, GA: Author.
13. Centers for Disease Control and Prevention. (2006a). Comprehensive risk counseling and services (CRCS): Implementation manual. Atlanta, GA: Author.
14. Centers for Disease Control and Prevention. (2006b). Social networks testing: A community-based strategy for identifying persons with undiagnosed HIV infection. Atlanta, GA: Author.
15. Cleary, P. D., Van Devanter, N., Rogers, T. F., Singer, E., Shipton-Levy, R., Steilen, M., et al. (1991). Behavior changes after notification of HIV infection. American Journal of Public Health, 81(12), 1586-1590 .
16. Coates, T. J., Grinstead, O. A., Gregorich, S. E., Sweat, M. D., Kamenga, M. C., Sangiwa, G., et al. (2000). Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet, 356(9224), 103-1112.
17. Cohen, D. A. , Wu, S. Y., & Farley, T. A. (2006). Structural interventions to prevent HIV/sexually transmitted disease: are they cost-effective forwomen in the southern United States? Sexually TransmittedDiseases, 33(7 Suppl.), S46-S49.
18. Cohen, M.S., Gay, C., Kashuba, A.D., Blower, S., Paxton, L. (2007). Antiretroviral therapy to prevent sexual transmission of HIV-1. Ann Intern Med, 146(8), 591-601.
19. Corey, L., Wald, A., Celum, C. L., & Quinn, T. C. (2004). The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of Acquired Immune Deficiency Syndromes, 35(5), 435-45.
20. Daar, E. S., Little, S., Pitt, J., Santangelo, J., Ho, P., Harawa, N., et al. (2001). Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Annals of Internal Medicine, 134(1), 25-29.
21. Daar, E. S., Moudgil, T., Meyer, R. D., & Ho, D. D. (1991). Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New England Journal of Medicine, 324(14), 961-964.
22. DiFranceisco, W., Pinkerton, S. D., Dyatlov, R. V., & Swain, G. R. (2005). Evidence of a brief surge in safer sex practices after HIV testing among a sample of high-risk men and women. Journal of Acquired Immune Deficiency Syndromes, 39(5), 606-612.
23. Fiebig, E.W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., et al. (2003). Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS, 17(13), 1871-1879.
24. Fiscus, S. A., Cheng, B., Crowe, S. M., Demeter, L., Jennings, C., Miller, V., et al. (2006). HIV-1 viral load assays for resource-limited settings. Public Library of Science Medicine, 3(10), e417.
25. Fisher, J. P. (2006). State's HIV testing inspires: Method detects AIDS virus earlier. The News & Observer, March 21, 2006.
26. Flanigan, T., & Tashima, K. T. (2001). Diagnosis of acute HIV infection: It's time to get moving! Annals of Internal Medicine, 134(1), 75-77.
27. Friedman, S. R. (1996). Network methodologies, contact tracing, gonorrhea, and human immunodeficiency virus. Sexually Transmitted Diseases, 23(6), 523-5.
28. Global Fund. (2005). Global Fund ARV Fact Sheet.
29. Hecht, F.M. , Busch, M. P., Rawal, B., Webb,M., Rosenberg, E., Swanson, M., et al. (2002). Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS, 16(8), 1119-1129.
30. Hecht, F. M. , Wang, L., Collier, A., Little, S., Markowitz, M., Margolick, J., et al. (2006). A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. Journal of Infectious Diseases, 194(6), 725-733.
31. Heckathorn, D. (1997). Respondent-driven sampling: A new approach to the study of hidden population. Social Problems, 44(2), 174-99.
32. Heckathorn, D., Broadhead, R., Anthony, D., & Weakliem, D. (1999). AIDS and social networks: HIV prevention through network mobilization. Sociological Focus, 32(2), 159-179.
33. Heckathorn, D. D. (2002).Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems, 49(1), 11-34.
34. Heckathorn, D. D., Semaan, S., Broadhead, R. S., & Hughes, J. J. (2002). Extensions of respondent-driven sampling: A new approach to the study of injection drug users aged 18-25. AIDS and Behavior, 6(1), 55-67.
35. Hewitt, K., Steketee, R., Mwapasa, V., Whitworth, J., & French, N. (2006 ). Interactions between HIV and malaria in non-pregnant adults: Evidence and implications. AIDS, 20(16), 1993-2004.
36. Hightow, L. B., MacDonald, P. D., Pilcher, C. D., Kaplan, A.H., Foust, E., Nguyen, T.Q., et al. (2005). The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students. Journal of Acquired Immune Deficiency Syndromes, 38(5), 531-7.
37. Jacquez, J. A., Koopman, J. S., Simon, C. P., & Longini, I. M. Jr. (1994). Role of the primary infection in epidemics of HIV infection in gay cohorts. Journal of Acquired Immune Deficiency Syndromes, 7(11), 1169-1184.
38. Jaffe, H. W., Rice, D. T., Voigt, R., Fowler, J., & St John, R. K. (1979 ). Selective mass treatment in a venereal disease control program. American Journal of Public Health, 69(11), 1181-1182 .
39. Kahn, J. O., Martin, J. N., Roland, M. E., Bamberger, J. D., Chesney, M., Chambers, D., et al. (2001). Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP Study. Journal of Infectious Diseases, 183(5), 707-714.
40. Kamenga, M., Ryder, R.W., Jingu, M., Mbuyi, N., Mbu, L., Behets, F., et al. (1991). Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: Experience at an HIV counselling center in Zaire. AIDS, 5(1), 61-67.
41. Kassler, W. J. (1997). Advances in HIV testing technology and their potential impact on prevention. AIDS Education Prevention, 9(3 Suppl.), 27-40.
42. Kinloch-de Loes, S. (2006). Treatment of acute HIV-1 infection: is it coming of age? Journal of Infectious Diseases, 194(6), 721-724.
43. Koopman, J. S., Jacquez, J. A., Welch, G.W., Simon, C. P., Foxman, B., Pollock, S. M., et al. (1997). The role of earlyHIV infection in the spread of HIV through populations. Journal of Acquired Immune Deficiency Syndromes andHuman Retrovirology, 14(3), 249-258.
44. Kublin, J. G., Patnaik, P., Jere, C. S., Miller, W. C. , Hoffman, I. F., et al. (2005). Effect of Plasmodium falciparum malaria on concentration ofHIV-1-RNA in the blood of adults in rural Malawi: A prospective cohort study. The Lancet, 365(9455), 233-240.
45. Lindback, S., Thorstensson, R., Karlsson, A. C., von Sydow, M., Flamholc, L., Blaxhult, A., et al. (2000). Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS, 14(15), 2333-2339.
46. Mathews, C., Coetzee, N., Zwarenstein, M., Lombard, C., Guttmacher, S., Oxman, A., et al. (2002). A systematic review of strategies for partner notification for sexually transmitted diseases, including HIV/AIDS. International Journal of STD AIDS, 13(5), 285-300.
47. Nagot, N., Ouedraogo, A., Foulongne, V., Konate, I., Weiss, H. A., Vergne, L., et al. (2007). Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. New England Journal of Medicine, 356(8), 790-799.
48. National Institute of Allergy and Infectious Diseases. (2006). Adult male circumcision significantly reduces risk of acquiring HIV. (Press release).
49. Okware, S., Kinsman, J., Onyango, S., Opio, A., & Kaggwa, P. (2005). Revisiting the ABC strategy: HIV prevention in Uganda in the era of antiretroviral therapy. Postgraduate Medical Journal, 81(960), 625-628.
50. Peterson, L., Taylor, D., Clarke, E. E., Doh, A. S., Phillips, P., Belai, G., et al. (2006 August 13-18). Findings from a double-blind, randomized, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) for prevention of HIV infection in women. Paper presented at the 16th International AIDS Conference, Toronto Canada.
51. Peterson, L. , Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanka, K., et al. (in press). Tenofovir disoproxil fumarate for prevention of HIV infenction in women: A phase 2, double-blind, randomized, placebo-controlled trial. Lancet, 26.
52. Pilcher, C. D., Eaton, L., Kalichman, S., Bisol, C., & de Souza Rda, S. (2006). Approaching "HIV elimination": Interventions for acute HIV infection. Current HIV/AIDS Report, 3(4), 160-168.
53. Pilcher, C. D., Fiscus, S. A.,Nguyen, T. Q., Foust, E., Wolf, L., Williams, D., et al. (2005). Detection of acute infections during HIV testing in North Carolina. New England Journal of Medicine, 352(18), 1873-1883.
54. Pilcher, C. D., McPherson, J. T., Leone, P. A., Smurzynski, M., Owen-O'Dowd, J., Peace-Brewer, A. L., et al. (2002). Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. Journal of the American Medical Association, 288(2), 216-221.
55. Pilcher, C. D., Price, M. A., Hoffman, I. F., Galvin, S., Martinson, F. E., Kazembe, P. N., et al. (2004a). Frequent detection of acute primary HIV infection in men in Malawi. AIDS, 18(3), 517-524.
56. Pilcher, C.D., Tien, H. C., Eron, J. J. Jr, Vernazza, P. L., Leu, S. Y., Stewart, P. W., et al. (2004). Brief but efficient: Acute HIV infection and the sexual transmission of HIV. Journal of Infectious Diseases, 189(10), 1785-1792.
57. Pinkerton, S. D.,Martin, J. N., Roland, M. E., Katz, M. H., Coates, T. J., & Kahn, J. O. (2004). Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS, 18(15), 2065-2073.
58. Potterat, J. J. (2003). Partner notification for HIV: Running out of excuses. Sexually Transmitted Diseases, 30(1), 89-90.
59. Preiser, W. ( 2005). HIV Testing. In C. Hoffmann, & J. Rockstroh (eds.), HIV medicine (pp. 41-58). Retrieved August 29, 2006 from http://www.hivmedicine.com/). Paris: Flying Publisher.
60. Quinn, T. C. (2006). Circumcision and HIV transmission: The cutting edge. Paper presented at the 13th Conference on Retroviruses and Opportunistic Infections Denver, CO.
61. Quinn, T. C. , Brookmeyer, R., Kline, R., Shepherd, M., Paranjape, R., Mehendale, S., et al. (2000a). Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS, 14(17), 2751-7275.
62. Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., et al. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal ofMedicine, 342(13), 921-929.
63. Ribas, S. G. , Ondoa, P., Schupbach, J., van der Groen, G., & Fransen, K. (2003). Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Journal of Virological Methods, 113(1), 29-34.
64. Rothenberg, R. (2001). How a net works: Implications of network structure for the persistence and control of sexually transmitted diseases and HIV. Sexually Transmitted Diseases, 28(2), 63-68.
65. Rothenberg, R. (2002). The transformation of partner notification. Clinical Infectious Diseases, 35(Suppl. 2), S138-S45.
66. Rothenberg, R., & Narramore, J. (1996). The relevance of social network concepts to sexually transmitted disease control. Sexually Transmitted Diseases, 23(1), 24-29.
67. Schupbach, J., Boni, J., Flepp, M., Tomasik, Z., Joller, H., & Opravil, M. (2001). Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. Journal of Medical Virology, 65(2), 225-232.
68. Streeck, H., Jessen, H., Alter, G., Teigen, N., Waring, M. T., Jessen, A., et al. (2006). Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. Journal of Infectious Diseases, 194(6), 734-739.
69. Suligoi, B., Massi, M., Galli, C., Sciandra, M., Di Sora, F., Pezzotti, P., et al. (2003). Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. Journal of Acquired Immune Deficiency Syndromes, 32(4), 424-428.
70. UNAIDS. (2005). UNAIDS reference group on estimates, modelling and projections' statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring (Press release).
71. UNAIDS. (2006). Overview of the global AIDS epidemic. Geneva, Switzerland: Author.
72. U.S. Food and Drug Administration. (2006). FDA approves test to help diagnose main virus that causes AIDS.
73. Wawer, M. J. , Gray, R. H., Sewankambo, N. K., Serwadda, D. , Li, X., Laeyendecker, O., et al. (2005). Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases, 191(9), 1403-149.
74. Wawer, M. J. , Sewankambo, N. K., Serwadda, D., Quinn, T. C., Paxton, L. A., Kiwanuka, N., et al. (1999). Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet, 353(9152), 525-535.
75. Weir, S.S., & Boerma, T. (2002). From people to places: Overview of the PLACE method and lessons learned. MEASURE Evaluation Bulletin, 4, 1-6.
76. Weir, S. S., Pailman, C., Mahlalela, X., Coetzee, N., Meidany, F., & Boerma, J. T. (2003). From people to places: Focusing AIDS prevention efforts where it matters most. AIDS, 17(6), 895-903.
77. West, G. R., & Stark, K. A. (1997). Partner notification for HIV prevention: A critical reexamination. AIDS Education Prevention, 9(3 Suppl.), 68-78.